Breath test

摘要

Asthmatics and those with other pulmonary disorders could soon benefit from a new generation of inhalers that instead of using a liquid aerosol spray, deliver the active ingredients as a fine powder. A new version of the dry powder inhaler concept, developed by Italian pharmaceutical company Chiesi Farmaceutici and UK design firm Cambridge Consultants, has made its debut at a major Pharmaceuticals conference in the US.